Home » Topics » BioWorld Science

BioWorld Science
RSS

Dopaminergic agents claimed by Sandoz

Sep. 13, 1996

ImmunoTherapeutics name change

Sep. 13, 1996

Stryker acquires Osteo

Sep. 13, 1996

Proposed acquisition agreement between Genzyme and Neozyme II

Sep. 13, 1996

Hybridon enters research collaborations for antisense therapies

Sep. 13, 1996

Sugen and ArQule drug discovery collaboration

Sep. 13, 1996

Broad patent coverage for Genelabs' drug discovery tool

Sep. 13, 1996

A major breakthrough in the treatment of schizophrenia

Sep. 13, 1996

New compounds from Roche with affinity for benzodiazepine receptors

Sep. 13, 1996

Merck & Co. synthesizes dopamine D4 receptor ligands

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...